18.95
Zimvie Inc stock is traded at $18.95, with a volume of 313.53K.
It is up +0.11% in the last 24 hours and up +1.17% over the past month.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
See More
Previous Close:
$18.93
Open:
$18.97
24h Volume:
313.53K
Relative Volume:
0.68
Market Cap:
$534.41M
Revenue:
$242.12M
Net Income/Loss:
$-351.72M
P/E Ratio:
-1.4259
EPS:
-13.29
Net Cash Flow:
$24.82M
1W Performance:
+0.53%
1M Performance:
+1.17%
6M Performance:
+42.37%
1Y Performance:
+11.21%
Zimvie Inc Stock (ZIMV) Company Profile
Name
Zimvie Inc
Sector
Industry
Phone
800-342-5454
Address
4555 RIVERSIDE DRIVE, PALM BEACH GARDEN
Compare ZIMV with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ZIMV
Zimvie Inc
|
18.95 | 534.41M | 242.12M | -351.72M | 24.82M | -13.29 |
![]()
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Zimvie Inc Stock (ZIMV) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-31-25 | Downgrade | B. Riley Securities | Buy → Neutral |
Jul-22-25 | Upgrade | Barclays | Underweight → Equal Weight |
Apr-10-25 | Initiated | B. Riley Securities | Buy |
Mar-13-25 | Downgrade | Needham | Buy → Hold |
May-16-24 | Upgrade | Needham | Hold → Buy |
Nov-16-23 | Initiated | Needham | Hold |
Dec-21-22 | Initiated | Barclays | Underweight |
Jun-17-22 | Initiated | JP Morgan | Neutral |
Mar-18-22 | Initiated | Guggenheim | Neutral |
View All
Zimvie Inc Stock (ZIMV) Latest News
ZIM's Q2 2025 Earnings and Strategic Outlook Amid ZimVie's Pending Acquisition: Clarifying the Market's Confusion - AInvest
ZimVie Inc. Approaches Support With Recovery in SightJuly 2025 Fed Impact & High Win Rate Trade Alerts - thegnnews.com
Synovus, ZimVie, Mesa, Royal Gold Under Investigation for Potential Securities Law Violations - AInvest
What MACD and RSI say about ZimVie Inc.Inflation Watch & Fast Exit and Entry Strategy Plans - Newser
ZimVie Inc. stock momentum explained2025 Institutional Moves & Risk Controlled Swing Trade Alerts - Newser
Forecasting ZimVie Inc. price range with options dataJuly 2025 Summary & Real-Time Stock Price Movement Reports - Newser
Using RSI to spot recovery in ZimVie Inc.Weekly Profit Summary & Consistent Return Investment Signals - Newser
Can swing trading help recover from ZimVie Inc. lossesTrade Entry Report & Fast Exit and Entry Strategy Plans - Newser
What makes ZimVie Inc. stock price move sharplyJuly 2025 Retail & Free Safe Entry Trade Signal Reports - Newser
What data driven models say about ZimVie Inc.’s future2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Reversal indicators forming on ZimVie Inc. stock2025 Breakouts & Breakdowns & Reliable Volume Spike Trade Alerts - Newser
ZimVie (ZIMV) Q2 EPS Doubles to $0.26 - AOL.com
What earnings revisions data tells us about ZimVie Inc.July 2025 Rallies & Low Drawdown Investment Strategies - Newser
Key metrics from ZimVie Inc.’s quarterly dataPortfolio Return Summary & Safe Capital Growth Stock Tips - Newser
Combining machine learning predictions for ZimVie Inc.Market Volume Summary & Technical Pattern Alert System - Newser
How to build a custom watchlist for ZimVie Inc.Quarterly Profit Summary & Smart Allocation Stock Reports - Newser
ZimVie to be acquired by Archimed for $19.00 per share in cash - MSN
Volume Surge May Signal Institutional Interest in ZimVie Inc.2025 Key Lessons & Scalable Portfolio Growth Methods - 선데이타임즈
Can ZimVie Inc. deliver consistent dividendsBreakout to Riches Picks - classian.co.kr
Will ZimVie Inc. see short term momentumHigh Probability Trade Plan with Indicators - Newser
Is ZimVie Inc. stock ready for a breakoutTrend Reversal Watch with Entry Signals - Newser
ZimVie Doubles — And Then Some — On Its Second Takeover Deal - MSN
What analysts say about ZimVie Inc. stockMaximize returns with strategic trading plans - Jammu Links News
Is ZimVie Inc. stock overvalued or undervaluedUnlock expert insights for smarter investing - Jammu Links News
Is ZimVie Inc. a growth stock or a value stockCapitalize on emerging market trends - Jammu Links News
What are ZimVie Inc. company’s key revenue driversInvest smarter with daily stock recommendations - Jammu Links News
What catalysts could drive ZimVie Inc. stock higher in 2025Get timely alerts on top-performing stocks - Jammu Links News
What drives ZimVie Inc. stock priceInvest smarter with comprehensive market analysis - Jammu Links News
What is ZimVie Inc. company’s growth strategyPhenomenal returns - Jammu Links News
When is ZimVie Inc. stock expected to show significant growthFree Trading Strategy Suggestions - Jammu Links News
What are analysts’ price targets for ZimVie Inc. in the next 12 monthsHigh-yield growth strategies - Jammu Links News
How does ZimVie Inc. generate profit in a changing economyMarket Forecast Signals For Fast Growth - Jammu Links News
What is the risk reward ratio of investing in ZimVie Inc. stockMarket Forecast Insights For 2025 - Jammu Links News
Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (SAGE) and ZimVie Inc (ZIMV) - The Globe and Mail
Does ZimVie Inc. stock perform well during market downturnsBreakout Stocks Watchlist That Work - jammulinksnews.com
ZimVie Tops Estimates But Preps For ARCHIMED Buyout - Finimize
B.Riley downgrades ZimVie stock rating to Neutral on acquisition news - Investing.com Canada
Real time alert setup for ZimVie Inc. performanceFree Growth Focused Entry Plan Suggestions - Newser
ZimVie Inc. Reports Q2 2025 Results Amid Acquisition - TipRanks
ZimVie earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Zimvie Inc Stock (ZIMV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zimvie Inc Stock (ZIMV) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Kidwell Heather | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
8,063 |
0 |
85,880 |
Kanaglekar Indraneel | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
10,966 |
0 |
64,830 |
Jamali Vafa | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
48,379 |
0 |
408,636 |
Heppenstall Richard | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
16,127 |
0 |
130,373 |
Jamali Vafa | See remarks below. |
Apr 01 '25 |
Option Exercise |
0.00 |
21,331 |
0 |
369,590 |
Schneider Sandra | Chief Accounting Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,590 |
0 |
33,252 |
Schneider Sandra | Chief Accounting Officer |
Mar 07 '25 |
Option Exercise |
0.00 |
6,542 |
0 |
31,415 |
Heppenstall Richard | See remarks below. |
Mar 10 '25 |
Option Exercise |
0.00 |
6,938 |
0 |
115,936 |
Heppenstall Richard | See remarks below. |
Mar 07 '25 |
Option Exercise |
0.00 |
24,650 |
0 |
115,337 |
Kanaglekar Indraneel | See remarks below. |
Mar 10 '25 |
Option Exercise |
0.00 |
4,163 |
0 |
54,878 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):